Skip to main content

Table 3 Market dynamics for FDC versions of 3TC/NVP/d4T40, ABC/3TC/ZDV and EFV/FTC/TDF

From: Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

 

2004

2005

2006

2007

2008

3TC/NVP/d4T40:

     

# Manufacturers *

2

5

3

4

3

# Approved Manufacturers

(WHO & FDA)

1

3

3

3

6

# Countries

21

38

32

21

7

Volume in person-years

55,758

126,005

114,178

103,690

14,810

Median annual price/person, USD (generic)

180

180

112

83

104

ABC/3TC/ZDV:

     

# Manufacturers*

3

2

1

1

3

# Approved Manufacturers

(WHO & FDA)

1

1

1

1

2

# Countries

3

6

2

3

2

Volume in person-years

61

250

106

479

129

Median annual price/person, USD (brand)

1,483

1,366

1,363

883

3,257

EFV/FTC/TDF:

     

# Manufacturers*

   

1

3

# Approved Manufacturers

(WHO & FDA)

  

1

2

2

# Countries

   

1

7

Volume in person-years

   

335

3,720

Median annual price/person, USD (brand)

   

712

613

  1. * # of manufacturers refers to the number of manufacturers who sold ARVs to donor recipients in a given year, as reported to either GFATM or WHO; this is NOT the total # of manufacturers in the market
Back to article page